Carlos Brotons

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Information provision for stroke patients and their caregivers

Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Stroke rehabilitation

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Universal Definition of Myocardial Infarction: Clinical Insights

Fourth Universal Definition of Myocardial Infarction (2018)

Can non-physician health-care workers assess and manage cardiovascular risk in primary care?

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

Universal Definition of Myocardial Infarction

Rapid rule out of acute myocardial infarction: novel biomarker-based strategies

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Coronary microvascular dysfunction in the clinical setting: from mystery to reality

Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist

Discrimination of patients with type 2 myocardial infarction

The Evolving Understanding and Approach to Residual Cardiovascular Risk Management

Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials

The 12-lead electrocardiogram as a predictive tool of mortality after acute myocardial infarction: Current status in an era of revascularization and reperfusion

Exercise Standards for Testing and Training

Early life determinants of adult blood pressure

Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic Regurgitation

Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years

The changing landscape of atherosclerosis

Maternal and child undernutrition: consequences for adult health and human capital

Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)/Stent for Life (SFL) groups

Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting

Update on acute coronary syndromes: the pathologists' view

Cardiac troponin level elevations not related to acute coronary syndromes

The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial

Long-Term Vasodilator Therapy in Patients with Severe Aortic Regurgitation

Mechanisms of NAFLD development and therapeutic strategies

Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments

Knowledge and adherence to antihypertensive therapy in primary care: results of a randomized trial

Clinical Pharmacokinetic, Pharmacodynamic, and Drug–Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor

How to use high-sensitivity cardiac troponins in acute cardiac care

Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds

Use of the Electrocardiogram in Acute Myocardial Infarction

Impact of rate-modulated pacing on quality of life and exercise capacity—Evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT)

Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia

The Year in Non–ST-Segment Elevation Acute Coronary Syndrome

Cardiac Rehabilitation and Cardiovascular Disability

Home-based versus centre-based cardiac rehabilitation

Depressive Symptoms and Health-Related Quality of Life

Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels

Atherosclerosis

Elevated Cardiac Troponin T in Patients With Skeletal Myopathies

Third Universal Definition of Myocardial Infarction

Health-Related Quality of Life Consequences of Implantable Cardioverter Defibrillators

Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

Heart failure with preserved left ventricular systolic function: a hospital cohort study

Global burden of blood-pressure-related disease, 2001

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol

Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients

Standardized End Point Definitions for Coronary Intervention Trials

Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention

ESC working group position paper on myocardial infarction with non-obstructive coronary arteries

Medication Adherence: WHO Cares?

Field-resolved infrared spectroscopy of biological systems

Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction

Prediabetes: a high-risk state for diabetes development

Aspirin Therapy in Primary Cardiovascular Disease Prevention

Age, treatment, and outcomes in high-risk non‐ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial

Molecular mechanisms of insulin resistance and associated diseases

Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Metabolic Alterations and Systemic Inflammation in Obstructive Sleep Apnea among Nonobese and Obese Prepubertal Children

Revisiting biomarker discovery by plasma proteomics

In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association

Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines?

Pathophysiology of Human Visceral Obesity: An Update

Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine

Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease

Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force

Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary

Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Interventions for enhancing medication adherence

Depression and Coronary Heart Disease

Are There Genetic Paths Common to Obesity, Cardiovascular Disease Outcomes, and Cardiovascular Risk Factors?

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies

Interventions for enhancing medication adherence

Incremental Prognostic Value of Biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) Score and High-Sensitivity Cardiac Troponin T in Non-ST-Elevation Acute Coronary Syndrome

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Pathophysiology of Sleep Apnea

Insulin Resistance, Insulin Response, and Obesity as Indicators of Metabolic Risk

Fourth Universal Definition of Myocardial Infarction (2018)

Part 8: Post–Cardiac Arrest Care

Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)

Cardiovascular Diseases in India

Fourth universal definition of myocardial infarction (2018)

Exercise for intermittent claudication

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force

Optimal In-Hospital and Discharge Medical Therapy in Acute Coronary Syndromes in Kerala

High-sensitivity cardiac troponin assays and unstable angina

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Medication Adherence

Is 6-month GRACE risk score a useful tool to predict stroke after an acute coronary syndrome?

Net Reclassification Improvement: Computation, Interpretation, and Controversies

Recommendations for Blood Pressure Measurement in Humans and Experimental Animals

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.

Linee guida ESC 2015 per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il Trattamento delle Sindromi Coronariche Acute nei Pazienti senza Sopraslivellamento Persistente del Tratto ST alla Presentazione della Società Europea di Cardiologia (ESC)

Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries

Predisposing Factors and Prognostic Value of Sustained Monomorphic Ventricular Tachycardia in the Early Phase of Acute Myocardial Infarction

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

Características basales y determinantes de la evolución en pacientes ingresados por insuficiencia cardíaca en un hospital general

Blood Pressure by Age in Childhood and Adolescence: A Review of 129 Surveys Worldwide

Consequences of using different methods to assess cardiovascular risk in primary care

Ensayo clínico aleatorizado para evaluar la eficacia de una intervención multifactorial para reducir las hospitalizaciones y mejorar la calidad de vida de los pacientes con insuficiencia cardíaca

Dietary advice in clinical practice: the views of general practitioners in Europe

Measuring functional status of chronic coronary patients: Reliability, validity and responsiveness to clinical change of the reduced version of the Duke Activity Status Index (DASI)

Guía europea de prevención cardiovascular en la práctica clínica: Adaptación española del CEIPC 2008

A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach?

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study

Ensayo clínico aleatorizado para evaluar la eficacia de un programa integral de prevención secundaria de las enfermedades cardiovasculares en atención primaria: estudio PREseAP

Strategy for optimal aortic regurgitation quantification by Doppler echocardiography: Agreement among different methods

Attenuated severity of new acute ischemic events in patients with previous coronary heart disease receiving long‐acting nitratesa

Randomized Clinical Trial to Assess the Efficacy of a Comprehensive Programme of Secondary Prevention of Cardiovascular Disease in General Practice: The PREseAP Study

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

A Single Factor Underlies the Metabolic Syndrome

Lipid Treatment Assessment Project 2